No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity

Published:2019-02-15 Issue:4 Volume:58 Page:477-485
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hirosawa Takuya¹,Morimoto Naoki¹,Miura Kouichi¹,Tahara Toshiyuki²,Murohisa Toshimitsu³,Okamura Yukishige⁴,Sato Takashi⁵,Numao Norikatsu⁶,Imai Masato⁷,Tano Shigeo⁸,Murayama Kozue⁹,Kurata Hidekazu¹⁰,Ozawa Iwao¹¹,Fukaya Yukimura¹²,Yoshizumi Hiroaki¹³,Watanabe Shunji¹,Tsukui Mamiko¹,Takaoka Yoshinari¹,Nomoto Hiroaki¹,Isoda Norio¹,Yamamoto Hironori¹

Affiliation:

1. Division of Gastroenterology, Department of Medicine, Jichi Medical University, Japan

2. Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Japan

3. Department of Gastroenterology, Dokkyo Medical University, Japan

4. Department of Gastroenterology, Sano Kousei General Hospital, Japan

5. Department of Gastroenterology, Nasu Red Cross Hospital, Japan

6. Department of Gastroenterology, Haga Red Cross Hospital, Japan

7. Department of Gastroenterological Surgery, Utsunomiya Memorial Hospital, Japan

8. Department of Gastroenterology, Shin-Oyama City Hospital, Japan

9. Department of Gastroenterology, Koga Red Cross Hospital, Japan

10. Department of Gastroenterology, Tochigi Medical Center Shimotsuga, Japan

11. Department of Hepatobiliary Surgery, Tochigi Cancer Center, Japan

12. Department of Internal Medicine, Nasu Minami Hospital, Japan

13. Department of Internal Medicine, Kamitsuga General Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/4/58_1194-18/_pdf

Reference19 articles.

1. 1. Tanaka J, Akita T, Ohisa M, et al. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepat 25: 363-372, 2018.

2. 2. Furusyo N, Kajiwara E, Takahashi K, et al. Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study. J Gastroenterol Hepatol 23: 1094-1104, 2008.

3. 3. Kanda T, Imazeki F, Azemoto R, et al. Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2. Dig Dis Sci 56: 3335-3342, 2011.

4. 4. Murata C, Kondo T, Tamakoski K, Yatsuya H, Toyoshima H. Factors associated with life space among community-living rural elders in Japan. Public Health Nurs 23: 324-331, 2006.

5. 5. Honda T, Katano Y, Shimizu J, et al. Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C. Liver Int 30: 527-537, 2010.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

2. Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection;Hepatology Research;2020-10-20

3. Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over;World Journal of Hepatology;2020-09-27

4. Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection;Journal of Rural Medicine;2020

5. Ribavirin/sofosbuvir;Reactions Weekly;2019-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3